Sergio Giralt

88PUBLICATIONS

417CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer diagnosisPsychology of ageing

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (88)

Sort by Publication Date:

|Jul 07, 2026

Concurrent administration of BCMA and GPRC5D chimeric antigen receptor (CAR) T cells in advanced multiple myeloma.

|Jun 15, 2026

Daratumumab therapy for refractory immune cytopenias after allogeneic hematopoietic cell transplantation.

|Apr 12, 2026

Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma.

Hamza Hashmi, Tara Sebastian, Sridevi Rajeeve

|Apr 09, 2026

Feasibility Study: Early Experiences With a Cancer Center's Virtual Expert Medical Opinion Program.

Allison Lipitz-Snyderman, Susan Chimonas, Brendan Raftery

|Apr 09, 2026

Eligibility versus appropriateness in allogeneic HCT.

Mohamed L Sorror, Andrew S Artz, Rebecca L Olin

|Feb 17, 2026

IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM.

Kylee H Maclachlan, Carlyn Rose Tan, Tala Shekarkhand

Pageof 15

Frequent Collaborators

42 joint publications

Miguel-Angel Perales

33 joint publications

Gunjan Shah

32 joint publications

Heather Landau

26 joint publications

Urvi Shah

24 joint publications

Malin L Hultcrantz

22 joint publications

Kylee Maclachlan

22 joint publications

Carlyn Tan

21 joint publications

Neha Korde

20 joint publications

Alexander M Lesokhin

18 joint publications

Sham Mailankody